Publications
Publications in 2019
Henrik Heiland D, Ravi VM, Behringer SP, Frenking JH, Wurm J, Joseph K, Garrelfs NWC, Strähle J, Heynckes S, Grauvogel J, Franco P, Mader I, Schneider M, Potthoff AL, Delev D, Hofmann UG, Fung C, Beck J, Sankowski R, Prinz M, Schnell O: Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun, 2019; 10 (1) (online): 2541. : http://dx.doi.org/10.1038/s41467-019-10493-6
Saleem H, Kulsoom Abdul U, Küçükosmanoglu A, Houweling M, Cornelissen FMG, Heiland DH, Hegi ME, Kouwenhoven MCM, Bailey D, Würdinger T, Westerman BA: The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation. Drug Resist Update, 2019; 43 (3): 29-37. : http://dx.doi.org/10.1016/j.drup.2019.04.002
Heynckes S, Daka K, Franco P, Gaebelein A, Frenking JH, Doria-Medina R, Mader I, Delev D, Schnell O, Heiland DH: Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme. Bmc Cancer, 2019; 19 (1) (online): 117. : http://dx.doi.org/10.1186/s12885-019-5308-y
Ricklefs FL, Maire CL, Reimer R, Dührsen L, Kolbe K, Holz M, Schneider E, Rissiek A, Babayan A, Hille C, Pantel K, Krasemann S, Glatzel M, Heiland DH, Flitsch J, Martens T, Schmidt NO, Peine S, Breakefield XO, Lawler S, Chiocca EA, Fehse B, Giebel B, Görgens A, Westphal M, Lamszus K: Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J Extracell Vesicles, 2019; 8 (1) (online): 1588555. : http://dx.doi.org/10.1080/20013078.2019.1588555
Delev D, Heiland DH, Franco P, Reinacher P, Mader I, Staszewski O, Lassmann S, Grau S, Schnell O: Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system. J Neuro-oncol, 2019; 141 (1): 223-233. : http://dx.doi.org/10.1007/s11060-018-03030-w
Rau A, Kellner E, Foit NA, Lützen N, Heiland DH, Schulze-Bonhage A, Reisert M, Kiselev VG, Prinz M, Urbach H, Mader I: Discrimination of epileptogenic lesions and perilesional white matter using diffusion tensor magnetic resonance imaging. The Neuroradiology Journal, 2019; 32 (1): 10-16. : http://dx.doi.org/10.1177/1971400918813991
Publications in 2018
Hoefflin R, Geißler AL, Fritsch R, Claus R, Wehrle J, Metzger P, Reiser M, Mehmed L, Fauth L, Heiland DH, Erbes T, Stock F, Csanadi A, Miething C, Weddeling B, Meiss F, von Bubnoff D, Dierks C, Ge I, Brass V, Heeg S, Schäfer H, Boeker M, Rawluk J, Botzenhart EM, Kayser G, Hettmer S, Busch H, Peters C, Werner M, Duyster J, Brummer T, Boerries M, Lassmann S, von Bubnoff N. Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience. JCO Precision Oncology 2018 :2, 1-16. https://ascopubs.org/doi/full/10.1200/PO.18.00105
Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O: One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned? J Neuro-oncol, 2018; 140 (2): 385-391. : http://dx.doi.org/10.1007/s11060-018-2964-8
Diamandis E, Gabriel CPS, Würtemberger U, Guggenberger K, Urbach H, Staszewski O, Lassmann S, Schnell O, Grauvogel J, Mader I, Heiland DH: MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classification. J Neuro-oncol, 2018; 139 (2): 431-440. : http://dx.doi.org/10.1007/s11060-018-2881-x
Heiland DH, Gaebelein A, Börries M, Wörner J, Pompe N, Franco P, Heynckes S, Bartholomä MD, Ó hAilín D, Carro MS, Prinz M, Weber S, Mader I, Delev D, Schnell O: Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme. Mol Cancer Res, 2018; 16 (4): 655-668. : http://dx.doi.org/10.1158/1541-7786.MCR-17-0680
Department of Neurosurgery
Neurocenter
Breisacher Str. 64
D-79106 Freiburg
Phone: +49 761 270-50010/-50020
Fax: +49 761 270-50240
neurochirurgie@uniklinik-freiburg.de